PROGNOSTIC IMPLICATION OF IPSS AND IPSS-R FOR PATIENTS WITH LOWER-RISK MDS TREATED WITH HYPOMETHYLATING AGENTS

被引：0
|
作者：
Moon, J. H. [1 ]
Sohn, S. K. [1 ]
Sook, A. Jae [2 ]
Kim, H. J. [2 ]
Song, M. K. [3 ]
Chung, J. S. [3 ]
Lim, S. N. [4 ]
Bae, S. H. [5 ]
机构：
[1] Kyungpook Natl Univ Hosp, Deagu, South Korea
[2] Cheonnam Natl Univ, Hwasun Hosp, Cheonnam, South Korea
[3] Busan Natl Univ Hosp, Pusan, South Korea
[4] Inje Univ, Paik Hosp, Pusan, South Korea
[5] Daegu Catholic Univ, Med Ctr, Deagu, South Korea
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P919
引用
收藏
页码：345 / 346
页数：2
相关论文
共 50 条
  • [41] PATIENTS WITH IPSS-R INTERMEDIATE RISK CAN BE SEPARATED INTO THREE RISK GROUPS
    Nachtkamp, K.
    Reykowski, T.
    Hildebrandt, B.
    Baldus, S.
    Rudelius, M.
    Neukirchen, J.
    Kuendgen, A.
    Strupp, C.
    Schroeder, T.
    Haas, R.
    Germing, U.
    LEUKEMIA RESEARCH, 2017, 55 : S147 - S147
  • [42] REPORT ON OUTCOME OF HYPOMETHYLATING THERAPY WITH ANALYSIS ON PROGNOSTIC VALUE OF REVISED-INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OF LOWER-RISK BASED ON IPSS
    Lee, Y.
    Moon, J.
    Yoon, J.
    Kim, J.
    Sohn, S.
    HAEMATOLOGICA, 2016, 101 : 507 - 507
  • [43] Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PM
    Sekeres, M.
    Ades, L.
    Tuechler, H.
    Sanz, G.
    Levis, A.
    Malcovati, L.
    Cazzola, M.
    Magalhaes, S. M. M.
    Luebbert, M.
    Haase, D.
    Schanz, J.
    Cermak, J.
    Garcia-Manero, G.
    Sole, F.
    Benett, J.
    Bowen, D.
    Dreyfus, F.
    Kantarjian, H.
    Kuendgen, A.
    Fonatsch, C.
    Le Beau, M.
    Slovak, M.
    Krieger, O.
    Maciejewski, J.
    Miyazaki, Y.
    Pfeilstoecker, M.
    Sperr, W.
    Stauder, R.
    Tauro, S.
    Valent, P.
    Vallespi, T.
    Van de Loosdrecht, A.
    Germing, U.
    Fenaux, P.
    Greenberg, P.
    LEUKEMIA RESEARCH, 2013, 37 : S74 - S75
  • [44] Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
    Della Porta, Matteo G.
    Alessandrino, Emilio Paolo
    Bacigalupo, Andrea
    van Lint, Maria Teresa
    Malcovati, Luca
    Pascutto, Cristiana
    Falda, Michele
    Bernardi, Massimo
    Onida, Francesco
    Guidi, Stefano
    Iori, Anna Paola
    Cerretti, Raffaella
    Marenco, Paola
    Pioltelli, Pietro
    Angelucci, Emanuele
    Oneto, Rosi
    Ripamonti, Francesco
    Bernasconi, Paolo
    Bosi, Alberto
    Cazzola, Mario
    Rambaldi, Alessandro
    BLOOD, 2014, 123 (15) : 2333 - 2342
  • [45] Outcomes by IPSS-R in lenalidomide-treated patients with IPSS low-/Int-1-risk MDSWith del(5q) in MDS-003 and MDS-004: A retrospective analysis
    Sekeres, M.
    Swern, A.
    Fenaux, P.
    Greenberg, P.
    Sanz, G.
    Bennett, J.
    Dreyfus, F.
    Cazzola, M.
    List, A.
    Garcia-Manero, G.
    Li, J. Shiansong
    Sugrue, M.
    LEUKEMIA RESEARCH, 2013, 37 : S69 - S70
  • [46] Refined cytogenetic IPSS-R evaluation by the use of SNP array in a cohort of 290 MDS patients
    Scarpelli, Ilaria
    Stalder, Valerie Beyer
    Tsilimidos, Gerasimos
    Rapakko, Katrin
    Costanza, Mariangela
    Blum, Sabine
    Schoumans, Jacqueline
    GENES CHROMOSOMES & CANCER, 2023, 62 (12): : 721 - 731
  • [47] WT-1 Expression Level In BM Is The Great Prognostic Marker In Three Of Classification IPSS, WPSS, and Latest Revised IPSS(IPSS-R)
    Kobayashi, Sumiko
    Ueda, Yasunori
    Kurokawa, Mineo
    Ogata, Kiyoyuki
    Shibayama, Hirohiko
    Emi, Nobuhiko
    Usuki, Kensuke
    Ohyashiki, Kazuma
    Ozawa, Keiya
    Miyazaki, Yasushi
    Matsuda, Akira
    Tohyama, Kaoru
    Mitani, Kinuko
    Naoe, Tomoki
    Sugiyama, Haruo
    BLOOD, 2013, 122 (21)
  • [48] IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
    Yang, Yi-Tsung
    Hou, Hsin-An
    Liu, Chieh-Yu
    Lin, Chien-Chin
    Chou, Wen-Chien
    Lee, Fen-Yu
    Liu, Ming-Chih
    Liu, Chia-Wen
    Tang, Jih-Luh
    Yao, Ming
    Li, Chi-Cheng
    Kuo, Yuan-Yeh
    Huang, Shang-Yi
    Ko, Bor-Sheng
    Chen, Chien-Yuan
    Hsu, Szu-Chun
    Lin, Chien-Ting
    Wu, Shang-Ju
    Tsay, Woei
    Chen, Yao-Chang
    Tien, Hwei-Fang
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (09) : E142 - E149
  • [49] Lymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry
    Silzle, T.
    Taylor, A.
    de Witte, T.
    Malcovati, L.
    Fenaux, P.
    Bowen, D.
    Symeonidis, A.
    Stauder, R.
    Cermak, J.
    Sanz, G.
    Hellstrom-Lindberg, E.
    Langemeijer, S.
    Holm, M. Skov
    Madry, K.
    Tatic, A.
    de Almeida, A. Medina
    Savic, A.
    Smoljanovic, I. Mandac
    Germing, U.
    Smith, A.
    SWISS MEDICAL WEEKLY, 2021, 151 : 30 - 30
  • [50] Comparison of the Molecular International Prognostic Scoring System (IPSS-M) and Revised International Prognostic Scoring System (IPSS-R) in predicting the prognosis of patients with myelodysplastic neoplasms treated with decitabine
    Nguyen, Quang Hao
    Vu, Minh Phuong
    Tran, Tuan Anh
    Duong, Quoc Chinh
    Vu, Duc Binh
    Nguyen, Ha Thanh
    Bach, Quoc Khanh
    ONCOLOGIE, 2024, 26 (02) : 323 - 328
12345